UJI DISOLUSI DAN KONDISI UJI DISOLUSI BIORELEVAN TABLET CANDESARTAN CILEXETIL

Candesartan cilexetil is antihypertensive agent belongs to Angiotensin Receptor Blocker (ARB) that classified into Biopharmaceutical Classification System (BCS) class II. Dissolution test is carried out to determine in vitro characteristic and performance of the drug. The result of dissolution tes...

Full description

Saved in:
Bibliographic Details
Main Author: T Pohan, Tania
Format: Final Project
Language:Indonesia
Online Access:https://digilib.itb.ac.id/gdl/view/50020
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Institut Teknologi Bandung
Language: Indonesia
id id-itb.:50020
spelling id-itb.:500202020-09-22T08:31:34ZUJI DISOLUSI DAN KONDISI UJI DISOLUSI BIORELEVAN TABLET CANDESARTAN CILEXETIL T Pohan, Tania Indonesia Final Project Candesartan cilexetil, dissolution, IV-IVC, biorelevant, similarity INSTITUT TEKNOLOGI BANDUNG https://digilib.itb.ac.id/gdl/view/50020 Candesartan cilexetil is antihypertensive agent belongs to Angiotensin Receptor Blocker (ARB) that classified into Biopharmaceutical Classification System (BCS) class II. Dissolution test is carried out to determine in vitro characteristic and performance of the drug. The result of dissolution testing sometimes is not correlated with the in vivo characteristics especially for the drug that has low solubility and permeability. Therefore, dissolution condition that can simulate in vivo condition is needed to get better correlation with the in vivo. This research was originally designed to develop the the dissolution test conditions of candesartan cilesetil tablet which have a good correlation with the in vivo result through the comparative dissolution test with its innovator product. This study include a literature review of various aspect related to development of dissolution test which estimated to have good in vitro-in vivo correlation through comparative dissolution test of various generic products with the innovator product. This literatur study show that biorelevant dissolution test for candesartan cilexetil tablet can be carried out using aparatus II (paddle) 50 rpm for 60 minutes with biorelevant medium such as FaSSGF, FaSSIF, FeSSGF, FeSSIF. However, due to very low solubility in the medium, sink condition cannot be achived at volumes that relate to physiological conditions. Experiments that have been done are making calibration curve using UV spechtrophotometer on three compendial dissolution mediums : HCl 0,1 N pH 1,2 0,7% Tween 20; dapar pH 4,5 0,7% Tween 20; dapar pH 6,8 0,7% Tween 20 and dissolution test for innovator product and copy product CC1 in phosphate buffer pH 6,8 0,7% Tween 20. Similarity factor (f2) of 6 unit dosage innovator product and CC1 product in phospate buffer pH 6,8 0,7% Tween 20 is 43,14. The two products are predicted to be not similar. text
institution Institut Teknologi Bandung
building Institut Teknologi Bandung Library
continent Asia
country Indonesia
Indonesia
content_provider Institut Teknologi Bandung
collection Digital ITB
language Indonesia
description Candesartan cilexetil is antihypertensive agent belongs to Angiotensin Receptor Blocker (ARB) that classified into Biopharmaceutical Classification System (BCS) class II. Dissolution test is carried out to determine in vitro characteristic and performance of the drug. The result of dissolution testing sometimes is not correlated with the in vivo characteristics especially for the drug that has low solubility and permeability. Therefore, dissolution condition that can simulate in vivo condition is needed to get better correlation with the in vivo. This research was originally designed to develop the the dissolution test conditions of candesartan cilesetil tablet which have a good correlation with the in vivo result through the comparative dissolution test with its innovator product. This study include a literature review of various aspect related to development of dissolution test which estimated to have good in vitro-in vivo correlation through comparative dissolution test of various generic products with the innovator product. This literatur study show that biorelevant dissolution test for candesartan cilexetil tablet can be carried out using aparatus II (paddle) 50 rpm for 60 minutes with biorelevant medium such as FaSSGF, FaSSIF, FeSSGF, FeSSIF. However, due to very low solubility in the medium, sink condition cannot be achived at volumes that relate to physiological conditions. Experiments that have been done are making calibration curve using UV spechtrophotometer on three compendial dissolution mediums : HCl 0,1 N pH 1,2 0,7% Tween 20; dapar pH 4,5 0,7% Tween 20; dapar pH 6,8 0,7% Tween 20 and dissolution test for innovator product and copy product CC1 in phosphate buffer pH 6,8 0,7% Tween 20. Similarity factor (f2) of 6 unit dosage innovator product and CC1 product in phospate buffer pH 6,8 0,7% Tween 20 is 43,14. The two products are predicted to be not similar.
format Final Project
author T Pohan, Tania
spellingShingle T Pohan, Tania
UJI DISOLUSI DAN KONDISI UJI DISOLUSI BIORELEVAN TABLET CANDESARTAN CILEXETIL
author_facet T Pohan, Tania
author_sort T Pohan, Tania
title UJI DISOLUSI DAN KONDISI UJI DISOLUSI BIORELEVAN TABLET CANDESARTAN CILEXETIL
title_short UJI DISOLUSI DAN KONDISI UJI DISOLUSI BIORELEVAN TABLET CANDESARTAN CILEXETIL
title_full UJI DISOLUSI DAN KONDISI UJI DISOLUSI BIORELEVAN TABLET CANDESARTAN CILEXETIL
title_fullStr UJI DISOLUSI DAN KONDISI UJI DISOLUSI BIORELEVAN TABLET CANDESARTAN CILEXETIL
title_full_unstemmed UJI DISOLUSI DAN KONDISI UJI DISOLUSI BIORELEVAN TABLET CANDESARTAN CILEXETIL
title_sort uji disolusi dan kondisi uji disolusi biorelevan tablet candesartan cilexetil
url https://digilib.itb.ac.id/gdl/view/50020
_version_ 1822272220085354496